Skip to main content

Applied Imaging Partners with Sanger to Develop Gene Expression Applications for Software

NEW YORK, April 29 - Applied Imaging is to be the exclusive imaging partner for the Wellcome Trust Sanger Institute's Atlas of Gene Expression project, the Santa Clara, Calif., company said today.

 

Under the agreement, Sanger will buy Applied Imaging's Ariol software for high-throughput analysis of tissue samples, which it will use for the Atlas of Gene Expression project. Applied will develop applications for the software that it will have commercial rights to sell.

 

The Atlas of Gene Expression project aims to globally map protein expression patterns in cells. The researchers will map expression in normal and disease states, and use recombinant antibodies for imaging and analysis, the Sanger Institute said.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.